Andere talen Ovid Therapeutics Inc.

Aandelen

OVID

US6904691010

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,7692 ^USD	+5,89%		-1,38%	-76,11%

18/06	OVID THERAPEUTICS INC. : Oppenheimer is niet langer positief gestemd	ZM
18/06	OVID THERAPEUTICS INC. : B. Riley geeft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID	24/06
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ovid Therapeutics Inc. - OVID	24/06
Ovid Therapeutics Reports on Takeda s Announcement of Phase 3 Topline Study Results for Soticlestat	18/06
Top Midday Decliners	17/06
Ovid Therapeutics Shares Slide Premarket After Takeda's Soticlestat Setback	17/06
Sector Update: Health Care Stocks Decline Premarket Monday	17/06
Investors Look for Fresh Impetus Ahead of Holiday Break, Stifling US Equity Futures Pre-Bell	17/06
Ovid Seeks Distance From Epilepsy Drug After Takeda Reports Phase 3 Endpoints Missed -- Pre-Bell Shares Fall	17/06
Top Premarket Decliners	17/06
Takeda's Soticlestat Misses Goals in Phase 3 Epilepsy Studies	17/06
Ovid Therapeutics : Corporate Presentation	17/06
Takeda's seizure drug fails to meet main goal in late-stage studies	17/06
Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat	17/06
Takeda Pharmaceutical Company Limited Announces Topline Data from its Phase 3 SKYLINE and SKYWAY Studies Evaluating Soticlestat for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome	17/06
Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000	14/05
Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results	14/05
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results	14/05
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference	13/05
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ovid Therapeutics Inc.

Aandelen

OVID

US6904691010

Andere talen

Filters